. Altered connexin 43 expression underlies age-dependent decrease of regulatory T cell suppressor function in nonobese diabetic mice.
T ype 1 diabetes (T1D) is a complex autoimmune disease resulting from destruction of pancreatic b-islets by infiltrating immune cells (1) . Both environmental and genetic factors contribute to the development of the disease in humans and in NOD mice, which constitute an animal model of diabetes (2) . Cellular mechanisms implicated in the progression of T1D include aberrant activation of autoreactive T cells, inefficient peripheral tolerance, and impaired function of immunoregulatory cells, especially CD4
+ regulatory T cells (T regs ) expressing the transcription factor Foxp3 (1, 3) .
T regs regulate homeostasis of the immune system and a variety of immune responses, including autoimmunity, and rely on numerous mechanisms that involve soluble, immunomodulatory cytokines, IL-10 and TGF-b, as well as membrane molecules and cell contact-dependent interactions (4, 5) . T regs may also sustain tolerance by converting effector CD4 + T cells into T regs . This mechanism of "infectious" tolerance relies on genetic reprogramming of effector cells to become T regs and involves intercellular transport of cAMP (6, 7) . The determinants of which suppression mechanisms are used in particular immune contexts remain poorly understood.
Two major subsets of T regs , thymus-derived (tT reg ) and peripherally derived T regs (pT reg ), were defined based on whether their suppressor function is acquired during normal thymic T cell development or after antigenic stimulation in peripheral lymphoid organs (8) . In vitro-induced T regs (iT regs ) may be generated by stimulation of CD4 + T cells in the presence of TGF-b and IL-2 (5). In vivo pT regs are induced by a specialized population of dendritic cells in a process dependent on TGF-b and retinoic acid (RA) (9) . Treatment of NOD mice with RA delayed the development of diabetes by inducing and expanding T regs , and by protecting islets from immune system-mediated destruction (10, 11) .
Several lines of evidence directly showed that T regs regulate autoimmunity in diabetes. Transfer of pT regs or iT regs into NOD mice, or in vivo induction of T regs , can protect NOD mice from diabetes (12) (13) (14) . Conversely, compromised function of T regs was found to induce or exacerbate diabetes (15, 16) . A number of genes associated with diabetes susceptibility loci regulate the survival and/or functions of T regs (e.g., CTLA4, IL-2, STAT5) (17) (18) (19) . Despite clear evidence of T reg influence on T1D development, it remains controversial as to what the changes are in the T reg population that actually contribute to the natural pathogenesis of diabetes in NOD mice. Although some studies suggested a primary defect in the number and/or suppressor function of T regs , other studies pointed to the resistance of effector T cells to T regmediated suppression as a possible mechanism of autoimmune diabetes (20) (21) (22) (23) (24) (25) . Some of the discrepancies in the experimental results may stem from the use of different markers (e.g., CD25 or Foxp3), to identify and isolate the T reg population.
To better define the cellular and molecular basis of impaired T reg function in diabetes, we examined populations of these cells in young, prediabetic and aged, diabetic NOD mice expressing a Foxp3 GFP reporter that allows for unambiguous identification of T regs . We have found that compromised suppression mediated by T regs was associated with decreased ability of conventional T cells to upregulate Foxp3 and convert into iT regs in aging NOD mice. We show that expression of connexin 43 (Cx43), a gap junction protein and one of the TGF-b-inducible genes, progressively declined in NOD mice progressing to diabetes. Gap junctions are essential for transporting cAMP from T regs into target T cells, which initiates the genetic program of inhibiting T cell activation (7, 26) . In this study, we found that dysregulated expression of Cx43 and alleviated cAMP signaling underlie progressive loss of T reg suppressor function in NOD mice. This signaling defect and impaired iT reg generation can be corrected by treatment of effector T cells with TGF-b, which promotes upregulation of Cx43, and RA, which regulates phosphorylation of connexin molecules and intercellular communication through gap junctions. Our data suggest that interactions that require cell contact and intercellular communication are compromised in aged T cells in NOD mice. Finally, using a novel reagent that inhibits a PDZ-based interaction of Cx43 with the scaffolding protein zona occludens-1 (ZO-1), we demonstrate that suppressor function could be augmented even in T regs isolated from NOD mice with diabetes.
Materials and Methods

Mice
NOD mice expressing Foxp3
GFP reporter (NOD GFP mice) were constructed as reported previously (27) . A fragment of Foxp3 locus (located on BAC clone RP23-446O15) was modified to express GFP controlled by the Foxp3 regulatory sequences. Transgenic mice were produced in Joslin Diabetes Center at Harvard University by injecting NOD oocytes. Founders were identified by PCR of tail DNA.
All control mice were healthy, 2-to 4-wk-old NOD GFP prediabetic females referred to in this text as young mice, and diseased animals, referred to as diabetic, were $20-wk-old females with diabetes (mice with blood glucose levels ,120 mg/dl were considered healthy and those with levels .300 mg/dl were considered diabetic). In some experiments, age-matched Foxp3 GFP reporter mice on the C57BL/6 (C57BL/6-Tg [Foxp3-GFP]90Pkraj/J; Jackson Labs) genetic background (B6 GFP mice) were used as additional controls. The incidence rate of diabetes in our colony was observed to be 85-90% for females and 15-20% for males.
Diabetes was induced in 5-to 6-mo-old female B6 GFP mice by streptozotocin injections. Streptozotocin (Sigma-Aldrich) was dissolved in 0.1 M citrate buffer (pH 4.5) and injected i.p. at a dose of 50 mg/kg/d for 5 d (28). Mice were sacrificed at day 14 after initial injection when blood glucose levels, measured for three consecutive days, were .350 mg/dl.
Full details of the study and all procedures performed on animals were approved by the Institutional Animal Care and Use Committee of the Georgia Regents University (approval #09-06-213) and complied with all state, federal, and National Institutes of Health regulations.
Cell purification, flow-cytometry analysis, and cell sorting Cells from peripheral (axillary, brachial, and inguinal), mesenteric, and pancreatic lymph node (LN), spleens, and thymi were stained with Abs specific for CD4, CD8, CD25, CD44, CD62L, CTLA4, GITR, pSTAT5, Helios, and anti-rat CD2 (rCD2; BD, eBioscience, Biolegend), and analyzed on a BD FACSCanto instrument. Cells were sorted on a MoFlo cell sorter (Beckman Coulter; purity of all sorts exceeded 98%). Data were analyzed using FlowJo (Tree Star).
Detection of p-STAT5
p-STAT5 was detected in CD4 + T cells isolated from pancreatic LNs from young and old NOD GFP mice and from B6 GFP mice by intracellular staining as described previously (29) . LN cells were cultured in complete media in the presence of IL-2 (10 ng/ml), stained with Abs specific for CD4, CD8, and CD25, washed, fixed, and stained with p-STAT5 Ab (pY694; BD).
Induction of Foxp3 expression
Sorted CD4
+
Foxp3
GFP2 cells were activated with plate-bound anti-CD3 (10 mg/ml) and anti-CD28 (1 mg/ml) Abs (Biolegend) in the presence of recombinant murine IL-2 (50 U/ml) and TGF-b (3 ng/ml) (both from Peprotech) and monitored daily for GFP and Foxp3 upregulation by flow cytometry and RT-PCR. Some wells contained RA (3 nM; Sigma-Aldrich). This experiment was done at least five times.
RT-PCR
Total RNA was isolated using the RNeasy Mini Kit (Qiagen) and converted into cDNA using the Superscript III kit (Invitrogen). Gene expression studies were performed using quantitative real-time PCR and TaqMan probes (Invitrogen). All data were normalized for b-actin expression, and expression differences were shown as relative expression. Data were acquired with ABI7900HT instrument. All primers had been used previously (27, 30) .
Analysis of Foxp3 expression in single cells was done as described previously. In brief, single cells were sorted from populations of CD4 +
Foxp3
GFP2 and T regs expressing low and high levels of Foxp3 directly into 96-well PCR plates containing reverse transcription buffer, and cDNA was synthesized. Foxp3 and b-actin transcripts were amplified by two rounds of PCR using nested primers: Foxp3: first round 59-GCCTG-CCACCTGGGATCAAT-39 and 59-CACAGATGGAGCCTTGGCCA-39 primers, second round 59-CACCCAGGAAAGACAGCAACC-39 and 59-CTTCTCCTTTTCCAGCTCCAGC-39; b-actin: first round 59-GACATG-GAGAAGATCTGGCACCA-39 and 59-CTCTTTGATGTCACGCACGATT-TC-39 and second round 59-CCTTCTACAATGAGCTGCGTGTGGC-39 and 59-CATGAGGTAGTCTGTCAGGTCC-39 primers (30, 31) . 4 cells/lane) and electrotransferred onto a PVDF membrane (Millipore). Membranes were probed with Ab specific for Foxp3 (1 mg/ml, eBio7979; eBioscience) as described previously (27) . For Smad2 and phospho-Smad2 detection, membranes were probed overnight (4˚C) with the corresponding Abs (Cell Signaling Technology). Images were scanned and analyzed using ImageQuant 5.2 software (GE). 
Western blot
Proliferation inhibition assay
Measurement of IFN-g
Flow-cytometry-sorted CD4 + Foxp3 GFP2 effector cells were mixed with increasing proportions of sorted CD4 + Foxp3 GFP+ T regs and irradiated splenocytes, and stimulated with soluble anti-CD3ε Ab as described earlier. Levels of IFN-g in the culture supernatant were measured in triplicates with commercial ELISA kit (eBioscience).
STAT5b and Cx43 overexpression
Full-length cDNA encoding a constitutively active form of STAT5b (STAT5b-CA; gift of Dr. A. Farrar, University of Minnesota) or Cx43 (Open Biosystems) were cloned into retroviral vector pMx-IRES-rCD2 expressing extracellular rat CD2 domain (gift of Dr. M. Iwashima, Loyola University). Retroviral particles were prepared in Phoenix-Eco packaging cell line (gift of Dr. G. Nolan, Stanford University), and culture media were used to infect target cells. Sorted CD4 For retroviral transduction of T regs , sorted Foxp3 GFP+ cells were activated overnight as described earlier in the presence of IL-2 (50 U/ml). Cells were then infected with Cx43-encoding or control virus and further expanded on anti-CD3/anti-CD28-coated plates in the presence of IL-2. Two days later, rCD2 expression was assessed by flow cytometry. T regs expressing a high level of rCD2 (.90%) were used as suppressors, and freshly sorted CD4 +
Foxp3
GFP2 cells were used as effector cells in proliferation inhibition assay.
Calcein loading and dye transfer iT regs and activated T cells were prepared from CD4 + T cells expressing transgenic TCR specific for pigeon cytochrome c antigenic peptide presented by I-A b (32) . iT regs were loaded with 0.5 mM calcein violet, AM (Invitrogen) according to manufacturer's instructions and stained with anti-CD4-allophycocyanin. Responder cells stained with anti-CD4-PE were mixed with iT regs and bone marrow-derived dendritic cells at 1:1:0.1 ratio in the presence (0.25 mM) or absence of antigenic peptide. Cells were seeded in a round-bottom 96-well plate, and calcein transfer into responder CD4-PE cells was recorded after 5 h using LSRII flow cytometer (BD) equipped with violet laser.
Statistical analysis
All data are presented as the mean values 6 SD. The significance of differences between samples or groups of mice was determined using paired, one-tailed Student t test. Differences between samples with p values #0.05 were considered significant. Statistical analysis was done using Origin 9.0 software (OriginLab).
Results
The suppressor function but not cell numbers of T regs decline in aged NOD mice
To uncover what cellular and molecular characteristics are associated with progression to disease, we have studied phenotypes and an abundance of CD4 + T cell subsets in peripheral and pancreatic LNs of young (2-4 wk) NOD mice with normal glucose levels (120 mg/dl) and diabetic NOD mice ($20 wk) with overt diabetes (.300 mg/dl glucose). To facilitate identification of T regs , we have produced Foxp3
GFP reporter mice (NOD GFP ). A modified BAC clone previously used to generate Foxp3 GFP reporter mice in the C57BL6 strain (B6 GFP ) was introduced into NOD oocytes ( Fig. 1A-D) (27) . Thus, the generation of our reporter mice did not involve backcrossing of transgenic founder animals onto an NOD genetic background. Transgenic reporter and wild type NOD mice had equivalent numbers, percentages, and cell-surface phenotypes of all T cell subsets, including CD4 + CD25 + T cells, in thymus, LNs, and spleen. Consistent with earlier reports, a normal, or even increased, proportion of Foxp3 GFP+ T cells was observed in NOD GFP mice of every age, including young and diabetic mice (Fig. 1E, 1F ) (24) . Moreover, we observed a moderate increase of T regs in peripheral and pancreatic LNs. Despite stable proportions of T regs , we observed phenotypic changes of T reg populations: cells from diabetic mice expressed lower levels of GITR, CTLA4, and Helios, but higher levels of CD39 and PD-1 ( Fig. 1G and data not shown). Aged NOD GFP mice had expanded populations of activated CD44 + CD62L
2 conventional CD4 + T cells in peripheral LNs including pancreatic LNs (Fig. 1H, 1I ). We have also observed enhanced proliferative responses of Foxp3 GFP2 effector cells stimulated in vitro, which correlated with increased blood glucose levels ( Fig. 1J, 1K ).
Because disease progression was not associated with declining proportions of T regs , we checked the ability of these cells to suppress the immune response. For that purpose, we examined T regs expressing low and high levels of Foxp3 from young and diabetic NOD GFP mice in a standard proliferation inhibition assay and compared these mice with diabetes-resistant B6 GFP mice. We consistently observed decreased capacity of T regs isolated from diabetic animals to inhibit proliferation of activated, conventional (CD4 + Foxp3 GFP2 ) Th cells from young NOD GFP mice ( Fig. 2A ). However, T regs from both young and diabetic NOD GFP mice had lower suppressor capacity than corresponding cells from B6 GFP mice. In a reciprocal experiment, T regs from young NOD GFP mice were able to significantly inhibit proliferation of effector CD4 + T cells from older, diabetic animals. Finally, proliferation inhibition was smallest when T regs and responder cells were both isolated from aged, diabetic mice (Fig. 2B) . To examine whether hyperglycemia could alter T reg functions, we have induced diabetes in 4-to 5-mo-old B6 mice by streptozotocin injection. This experiment shows comparable inhibition of proliferation and IFN-g production by cells isolated from normal and hyperglycemic mice, demonstrating that observed differences in T reg suppression are likely not caused by differences in blood glucose levels (Supplemental Fig. 1A, 1B) . Together, our data demonstrate that functional, not quantitative, changes of T regs are associated with disease progression in NOD mice. Higher proportion of T regs from old NOD mice than from young and aged B6 mice is needed to achieve the same level of suppression, suggesting that immune environment permissive for autoimmune disease already exists before overt diabetes.
Effector CD4 + T cells and Foxp3
GFPlo T regs from diabetic mice have decreased ability to upregulate Foxp3 expression when activated in the presence of IL-2 and TGF-b
We have routinely observed that a small, but consistent proportion of sorted naive CD4 + T cells from B6 GFP mice upregulated Foxp3 when activated in vitro without exogenous IL-2 and TGF-b (30) . In NOD mice, we noticed that a larger fraction of effector cells from young NOD GFP mice than from older mice upregulated Foxp3 when cells were activated in vitro (Fig. 3A) . This agedependent decline in the ability of effector T cells to upregulate Foxp3, not seen in aging B6 GFP mice, suggests reduced and delayed capacity to generate iT regs in aged NOD mice (Fig. 3B) .
Consistent with our previous analysis of B6 GFP reporter mice, we examined whether the population of T regs in NOD GFP mice is heterogeneous, with cells being differentially sensitive to Ag/ cytokine stimulation. To examine how Foxp3 is regulated in T cell subsets in young and aged NOD GFP mice, we activated conventional CD4 +
Foxp3
2 cells and Foxp3 lo and Foxp3 hi T regs with plate-bound anti-CD3/anti-CD28 Abs without and in the presence of TGF-b and IL-2 (33) . A large proportion of Foxp3 hi T regs , which constituted a majority of the T reg population, preserved a stable T reg phenotype in young and old NOD GFP mice when activated (Fig. 3C, 3D ). In contrast, conventional Foxp3 2 cells and Foxp3 lo T regs from aged NOD GFP mice have a decreased ability to upregulate and/or maintain Foxp3 expression compared with the respective populations from young mice. In particular, the Foxp3 lo subset in aged mice had an unstable T reg phenotype, and only a small proportion of these cells was able to sustain Foxp3 expression when stimulated with anti-CD3/anti-CD28 Abs even in the presence of TGF-b (Fig. 3D) . Altogether, our results suggest that CD4 + T cell populations, identified in previous reports as precursors of pT regs , are most affected by the dysregulated expression of Foxp3 in aging NOD mice.
Dysregulated upregulation/expression of Foxp3 in aged NOD mice is associated with decreased signaling through STAT5 and Smad2/3
To delineate molecular mechanisms of age-related weakening of T reg suppression, we examined regulation of Foxp3 expression by IL-2 and TGF-b. IL-2 and TGF-b are cytokines critical for generation and maintenance of peripheral T regs (34) . Previous studies have shown that components of the IL-2 signaling pathway map to diabetes susceptibility loci (19, 35, 36) . Mutations of STAT5, a component of the IL-2R signaling pathway, were associated with impaired function of T regs in NOD mice (18) . Similarly, TGF-b, acting through Smad2/3, was found to regulate genes controlling T reg functions and insulin-specific T regs (37, 38) . Decreased expression and/or phosphorylation of STAT5 or Smad2/3 could suggest impaired signaling by IL-2 and TGF-b receptors, and explain decreased T reg suppression in aging NOD mice. To test this hypothesis, we studied protein expression-and signalinginduced phosphorylation of STAT5 or Smad2/3 in young and diabetic NOD mice. As shown in Fig. 4A and 4C, T cells from peripheral and pancreatic LNs of young and diabetic NOD GFP mice express similar levels of STAT5, but much lower levels of Smad2/3. When activated in the presence of IL-2 and TGF-b, decreased levels of STAT5 and Smad2/3 phosphorylation were found in T cells from diabetic mice (Fig. 4B, 4D ). When compared with B6 GFP mice, decreased STAT5 phosphorylation was found even in CD4 + T cells from young mice (Fig. 4B) . A recent report demonstrated that mice with a constitutively active form of STAT5 have more T regs (39) . To determine whether increased STAT5 signaling promotes Foxp3 upregulation, we transduced CD4 + T cells from NOD GFP and B6 GFP mice with a retroviral vector expressing a constitutively active STAT5 mutant (gift of Dr. M. Farrar) and activated them in the presence of IL-2 and TGF-b (40) . Enhanced signaling mediated by STAT5 resulted in an increased proportion of cells upregulating Foxp3 only in effector cells isolated from B6 GFP mice (Supplemental Fig. 2) . Collectively, examining STAT5 and Smad2/3 shows that impaired signaling by IL-2 and TGF-b likely contributes to age-dependent decrease of T reg functions in diabetic NOD mice.
Decreased expression/upregulation of Cx43 in old NOD mice underlies impaired suppressor function of T regs
In an attempt to restore Foxp3 upregulation in T cells isolated from diabetic NOD GFP mice to the levels observed in young NOD GFP mice, we treated naive cells isolated from diabetic NOD GFP mice with RA. As shown in Fig. 5A , addition of RA to T cells activated in the presence of IL-2 and TGF-b resulted in a significant increase in the proportion of iT regs . Effector cells from both young and diabetic NOD GFP mice upregulated Foxp3 with the same kinetics and produced the same percentage of iT regs at the conclusion of culture.
One of the TGF-b-and RA-induced genes essential for T reg development, Foxp3 expression, and contact-dependent suppression is Cx43 (26, 41) . This gene is not expressed in naive CD4 + T cells in steady-state mice, but it is expressed in cells with activated phenotype and in T regs , especially T reg subset expressing low levels of Foxp3.
Cx43 is a major gap junction protein in T lymphocytes, and intercellular transport of cAMP between activated T regs and target CD4 + T cells was shown to inhibit upregulation of CD69, IL-2 gene expression, and cellular proliferation (26 (Fig. 5B) . This result is consistent with a report demonstrating intercellular transport mediated by Cx43 recruited into immunological synapse (42) . To further examine Cx43 involvement in T reg suppression, we have generated iT regs from Cx43-sufficient and -deficient CD4 + T cells. iT reg -expressing natural levels of Cx43 proved to better inhibit activation of Cx43-sufficient T cells (Fig. 5C ). In summary, previously published and current data show how levels of Cx43 regulate intercellular, gap junction-mediated transport and impact T reg -mediated suppression.
To study how Cx43 could contribute to altered T reg function, we examined its expression pattern in CD4 + T cells in young and diabetic NOD mice. Analysis of CD4 + T cell subsets sorted directly from experimental mice established a baseline for Cx43 expression and revealed low expression in activated and Foxp3 lo T regs in diabetic NOD GFP mice (Fig. 5D) . Moreover, Cx43 is upregulated to much higher levels only in activated and T regs from young, but not diabetic NOD GFP mice, especially in the presence of TGF-b and in the absence of RA (Fig. 5E, 5F ).
Age-related changes in the Cx43 expression coincide with the loss of T reg function and suggest that the T reg suppression mechanism that relies on generation and intercellular transfer of cAMP might be progressively compromised in aging NOD GFP mice (7). To further elucidate this mechanism, we compared expression of adenylyl cyclases and phosphodiesterase, enzymes that regulate cAMP levels, in young and diabetic NOD GFP mice (43) . high (s, O, ) ) levels of Foxp3. Gating strategy to isolate T regs expressing low and high levels of Foxp3 is shown in Fig. 1C enzymes that increase intracellular cAMP concentration in T lymphocytes, are low in resting T regs and are upregulated upon activation in T regs isolated from young and diabetic NOD GFP mice. Despite lower expression of cyclases in activated T regs from diabetic NOD GFP mice, especially of adenylyl cyclase 7, all cyclases are significantly upregulated when compared with unstimulated T regs . Expression of phosphodiesterase 3b, a major cAMP-degrading enzyme in T regs , does not increase in cells from diabetic NOD GFP mice upon T reg activation (Fig. 6A) (44) . Because transcription of the phosphodiesterase gene is downregulated by Foxp3, our data suggest that Foxp3 is still able to control transcription of its target genes even in aging NOD GFP mice. Altogether, we conclude that, despite finding dysregulated expression of one adenylyl cyclase, expression of enzymes that control balance between cAMP generation and hydrolysis does not considerably change between young and old NOD GFP mice. Thus, low expression of Cx43 in diabetic NOD GFP mice likely results in decreased intercellular transport of cAMP, which could contribute to decreased suppressor function of T regs in these mice.
To test this hypothesis, we overexpressed Cx43 in expanded T regs in vitro. T regs expressing higher levels of Cx43 were more efficient in inhibiting proliferation and IFN-g production than the same cells expressing only low levels of Cx43 (Fig. 6B, 6C ). Increased suppression of T regs overexpressing Cx43 closely matches and compensates for the reduction of suppression seen between T regs isolated from young and diabetic mice. Both inhibition of proliferation and IFN-g production were abrogated by reagents that restrict intercellular communication through gap junctions, a-glycyrrhetinic acid, and connexin extracellular loop mimetic peptide (Gap26), further demonstrating that overexpression of Cx43 enhances T reg function by facilitating contact-dependent suppression (Fig. 6D, 6E) (45, 46) . In summary, both cell proliferation and IFN-g production are affected by decreased or increased function of Cx43 in T regs , prompting a possibility that Cx43-dependent mechanisms could be targeted to modulate T reg suppression (3, 4) .
Redistribution of Cx43 within plasma membrane that promotes gap junction formation and intercellular transport improves suppressor function of T regs in aged NOD mice Intercellular communication through gap junctions depends on interaction of two connexons (hemichannels), which are hexamers of Cx43 forming a transmembrane channel, each contributed by the contacting cell (47) . Cx43 assembled in gap junctions and in the adjacent domain, called perinexus, is associated with the ZO-1 protein through its C terminus. Disrupting interactions between Cx43 and ZO-1 increased the proportion of connexon hemichannels docked to gap junctions relative to connexons in the perinexus, increased size of gap junction plaques, and facilitated intercellular communication (48) . Because ZO-1, as well as Cx43, are expressed in T regs upon activation, interactions between these two proteins may control the extent of gap junction formation and increase T reg suppression. To test this hypothesis, we disrupted interaction between ZO-1 and Cx43 using peptide reagent that mimics C terminus of Cx43 (49) . This reagent, called aCT-1, is engineered to enter cytoplasm and bind the PDZ2 domain of ZO-1, competitively inhibiting its interaction with the C terminus of Cx43. We measured inhibition of proliferation and IFN-g production in the absence and presence of aCT-1 using responder and T regs isolated from normal B6 mice. As shown in Fig. 7A , aCT-1 increased intercellular communication between T reg and target cells, shown by calcein transport. Addition of aCT-1 was associated with increased suppressor function of T regs as demonstrated by proliferation inhibition assay and IFN-g production (Fig. 7B) . T regs isolated from mice with Cx43 gene deleted in T cells were not affected by presence of aCT-1 (Fig. 7C) . Considering that Cx43 expression is decreased in T regs from diabetic NOD GFP mice, we reasoned that suppressor function could be augmented in these cells by increasing proportion of Cx43 available to form gap junctions. In fact, we consistently noticed that aCT-1 improved suppressor function of T regs isolated from peripheral and pancreatic LNs of young and diabetic NOD GFP mice and streptozotocintreated B6 mice, as demonstrated by inhibition of proliferation and IFN-g production ( Fig. 7D-G, Supplemental Fig. 1C, D) . Increased suppression of T regs was most apparent when these cells constituted a small fraction of all T cells (5-10%) in the assay, close to the natural proportion of T regs in the lymphocyte population. This new reagent enhances gap junction-mediated suppression mechanism, and may allow for compensation of T reg deficit without the need to correct the underlying molecular deficit, for example, decreased Cx43 upregulation in diabetic NOD mice.
The data presented open a possibility that T regs , even in diabetic mice, retain suppressive potential that could be unmasked by treatments that compensate for decreased expression and function of key molecules mediating T reg functions.
Discussion
To better understand molecular processes associated with diabetes development, we examined CD4 + T cell subsets using a new Foxp3 GFP reporter mouse, produced on a pure NOD genetic background. This analysis suggests that, similar to C57BL6 mice, the population of T regs in NOD GFP mice is heterogeneous with regard to the level and stability of Foxp3 expression (30, 50) . Our study extends earlier reports that T reg function deteriorates in aged NOD mice and identifies T regs expressing low levels of Foxp3 and conventional CD4
+ T cells as cell populations that are mostly affected by age-related dysregulation of Foxp3 expression (22, 51) . This is consistent with the recent report that a significant fraction (∼20%) of all T regs may lose Foxp3 expression (16) . Our data suggest that loss and/or downregulation of Foxp3 expression might be caused by impaired signaling by IL-2 and TGF-b as demonstrated by decreased phosphorylation of STAT5 and Smad2 in aged mice, even in optimal concentration of both cytokines. IL-2 and TGF-b are major cytokines that support peripheral maintenance of tT regs and generation of pT regs upon antigenic stimulation (34) . pT regs were specifically identified as suppressor cells protecting NOD mice subject to immunotherapy with anti-CD3 Ab, and their decreased generation in older NOD mice could be regarded as a contributing factor for diabetes development (14) . We have previously suggested that continuous upregulation and downregulation of Foxp3 in conventional CD4 + T cells in response to self-Ags could be an important mechanism of immune tolerance and, based on current data, one could speculate that altered kinetics of this process may impact immunoregulation in NOD mice (30) .
The finding that Cx43, a molecule essential for T reg suppression and regulated by TGF-b, is only weakly upregulated in activated CD4 + T cells in NOD GFP mice progressing to diabetes complements earlier studies that dysregulation of TGF-b-dependent genes might be an important molecular feature of progression to diabetes (38) . Loss-and gain-of-function studies undertaken in this article identify Cx43 as a molecule that directly mediates T reg suppression. Moreover, this Cx43 dependence is not regulated by Foxp3, which is consistent with previous reports that functional features and transcriptional signature of T regs are controlled by Foxp3-dependent and -independent genes (27, 52) . The outcome of decreasing expression of TGF-b-dependent genes in the course of progression to diabetes might be magnified in the case of Cx43 by developing hyperglycemia. Both expression of Cx43 and transport through gap junctions are decreased by hyperglycemia (53, 54) . Thus, progression to clinical disease likely combines immunological and metabolic factors that form a positive feedback loop and amplify each other.
Expression of Foxp3 and Cx43 is greatly enhanced in activated CD4 + T cells from aged NOD GFP mice by RA, and in vitro generation of iT regs is restored to the level seen in young mice. This outcome shows that coordinate signaling, known to use different pathways, is able to compensate for the signal transduction deficit observed in aged cells. In recent reports, RA was shown to inhibit T1D progression, and our data demonstrate that one of the underlying molecular mechanisms of its effect could be to compensate for the age-dependent decline in the ability to upregulate and maintain Foxp3 and Cx43 expression in T regs (10, 11) . A recent report, however, shows that RA may also decrease specific phosphorylations of Cx43 that lead to increases in intercellular communication through gap junctions revealing complexity of regulatory mechanisms acting directly at the protein level or indirectly through regulating gene expression (55) . This activity of RA is most likely due to directly enhancing association between Cx43 and protein phosphatase 2A, because it does not depend on transcription or new protein synthesis. Altogether, the current and previous reports extend our understanding of how RA regulates T regs suppression, especially in the context of diabetes development. It also highlights how interactions between immune system and environmental factors (e.g., diet) may promote or prevent disease progression.
Intercellular communication mediated by gap junctions has been proposed as an important mechanism of T reg suppression (7, 26) . iT regs generated in vitro from CD4 + T cells isolated from B6 mice that have two, one, or no functional Cx43 gene alleles have progressively lower suppression (41) . In this study, by examining Cx43 gene expression pattern in effector cells and T regs directly isolated from young (prediabetic) and diabetic mice, or activated in vitro, we attempted to explain how intercellular communication, mediated by Cx43, may mechanistically contribute to immune regulation of diabetes in NOD mice. We have introduced a novel reagent, the Cx43 mimetic peptide aCT-1, to promote T reg -mediated suppression. Distinct from Gap26, the other mimetic peptide used in this study that inhibits both hemichannels and gap junction channels, aCT-1 selectively reduces hemichannel activity, whereas promoting gap junction plaque formation (48) . This is achieved by a novel mechanism in which aCT-1 releases undocked hemichannels from ZO-1 PDZ2 tethering at the plaque edge (i.e., the perinexus), prompting them to dock into gap junctions, thereby resulting in a loss of hemichannel activity and a complementary gain of gap junction function. Our results show that aCT-1 serves as a new experimental tool demonstrating that T regs , even in diabetic, hyperglycemic mice, preserve T reg suppressor capacity, which can be, at least partially, restored. It is also notable that Cx43 hemichannels have key assignments in the inflammatory response, acting as conduits for the release of proinflammatory mediators such as ATP (56) . Inhibition of hemichannel activity by promoting gap junction formation thus may represent a further factor to consider in the maintenance of b cells. Dysregulated expression of Cx43 in smooth muscle cells and altered communication through gap junctions were reported in diabetes patients and were considered as a contributing factor in the development of diabetes complications including vascular retinopathy (54, 57) . In phase II clinical testing, aCT-1 improves healing of diabetic foot ulcers and venous leg ulcers-pathologic, slow-healing wounds that are caught in chronic inflammatory states (58) . This report shows that Cx43 functions are compromised in T regs , directly involved in controlling immunological mechanisms leading to the destruction of pancreatic islets. Exploiting these mechanisms further may lead to a better understanding of immune regulation in diabetes and to the development of new therapies for diabetes and other autoimmune diseases. In conclusion, we hope our report contributes to better understanding of signaling pathways and individual molecules in regulating immune suppression mediated by T regs in NOD mice. Disclosures R.G. is an uncompensated member of the scientific advisory board and has modest stock interest (,5% ownership) in FirstString Research Inc., the company that is developing aCT-1 for indications in skin wound healing. The other authors have no financial conflicts of interest.
